Eugene J Midlock Net Worth

The estimated Net Worth of Eugene J Midlock is at least 366 千$ dollars as of 9 January 2012. Eugene Midlock owns over 3,375 units of Cooper Companies stock worth over 366,221$ and over the last 19 years Eugene sold COO stock worth over 0$.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Eugene Midlock COO stock SEC Form 4 insiders trading

Eugene has made over 4 trades of the Cooper Companies stock since 2011, according to the Form 4 filled with the SEC. Most recently Eugene exercised 3,375 units of COO stock worth 366,221$ on 9 January 2012.

The largest trade Eugene's ever made was exercising 45,000 units of Cooper Companies stock on 13 April 2011 worth over 1,696,500$. On average, Eugene trades about 9,240 units every 21 days since 2005. As of 9 January 2012 Eugene still owns at least 3,375 units of Cooper Companies stock.

You can see the complete history of Eugene Midlock stock trades at the bottom of the page.

What's Eugene Midlock's mailing address?

Eugene's mailing address filed with the SEC is 6140 STONERIDGE MALL ROAD, SUITE 590, PLEASANTON, CA, 94588.

Insiders trading at Cooper Companies

Over the last 21 years, insiders at Cooper Companies have traded over 45,273,696$ worth of Cooper Companies stock and bought 5,157 units worth 1,262,486$ . The most active insiders traders include Robert S Weiss、William A Kozy、Lawrence Erik Kurzius. On average, Cooper Companies executives and independent directors trade stock every 18 days with the average trade being worth of 1,325,775$. The most recent stock trade was executed by Brian G Andrews on 5 September 2024, trading 24,788 units of COO stock currently worth 939,713$.

What does Cooper Companies do?

company overview the cooper companies, inc. ("cooper"​) is a global medical device company publicly traded on the nyse euronext (nyse:coo). cooper is dedicated to being a quality of life company™ with a focus on delivering shareholder value. cooper operates through two business units, coopervision and coopersurgical. coopervision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. coopersurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. headquartered in pleasanton, ca, cooper has approximately 9,000 employees with products sold in over 100 countries. for more information, please visit www.coopercos.com.

Complete history of Eugene Midlock stock trades at Cooper Companies

Cooper Companies executives and stock owners

Cooper Companies executives and other stock owners filed with the SEC include:

• Albert White,
  President, Chief Executive Officer, Director
• Daniel McBride,
  Chief Operating Officer, Executive Vice President, President of CooperVision, Inc.
• Holly Sheffield,
  President - CooperSurgical
• Brian Andrews,
  Chief Financial Officer, Senior Vice President, Treasurer
• Albert G. White III,
  Pres, CEO & Non-Independent Director
• Agostino Ricupati,
  Senior Vice President - Finance and Tax, Chief Accounting Officer
• Daniel G. McBride Esq.,
  Exec. VP & COO
• Holly R. Sheffield,
  Pres of CooperSurgical, Inc.
• Brian G. Andrews,
  Exec. VP, CFO & Treasurer
• A. Thomas Bender,
  Independent Chairman of the Board
• Allan Rubenstein,
  Independent Vice Chairman of the Board, Lead Director
• Jody Lindell,
  Independent Director
• Gary Petersmeyer,
  Independent Director
• Colleen Jay,
  Independent Director
• William Kozy,
  Independent Director
• Robert Weiss,
  Director
• Teresa Madden,
  Independent Director
• Kim Duncan,
  Vice President of Investor Relations and Administration
• Randal Golden,
  Vice President, General Counsel, Secretary
• Juan Carlos Aragón,
  Pres of CooperVision Specialty EyeCare Division
• Mark J. Drury,
  VP, Gen. Counsel & Corp. Sec.
• Agostino Ricupati,
  Sr. VP of Fin. & Tax and Chief Accounting Officer
• Carol R Kaufman,
  VP Legal Affairs, Sec. and CAO
• Paul L Remmell,
  COO, VP Finance-CSI
• Tina Maloney,
  Corporate Controller
• Gregory W Matz,
  VP & CFO
• Stanley Md Zinberg,
  Director
• Michael Kalkstein,
  
• Nicholas J Pichotta,
  
• Rodney Folden,
  Corporate Controller
• Donald Press,
  Director
• Steven Rosenberg,
  Director
• Jeffrey Alan Mc Lean,
  Pres - U.S. Ops - CVI
• Dennis Murphy,
  President Americas, CVI
• Moses Marx,
  Director
• Andrew Sedgwick,
  Managing Dir., Europe of CVI
• Eugene J Midlock,
  Vice President, Taxes
• John J Calcagno,
  CFO and VP Bus. Dev.
• John Arthur Weber,
  Vice Pres Worldwide Ops-CVI
• J Christopher Marmo,
  VP, R&D of CooperVision, Inc.
• John D Fruth,
  Director
• B Norris Battin,
  
• Edgar J Cummins,
  Director
• Steven M Neil,
  CFO
• David Acosta,
  Treasurer
• Companies Inc Cooper,
  Director
• Gregory A Fryling,
  COO - CVI
• James M Welch,
  Vice President Intl Ops - CVI
• Stephen Whiteford,
  VP, Corporate Controller
• Robert D Auerbach,
  Special Advisor to the CEO
• Mark J Drury,
  VP, General Counsel & Sec.
• Maria Rivas,
  
• Gerard H Iii Warner,
  President, CooperVision, Inc.
• Nicholas Khadder,
  VP, General Counsel & Corp Sec
• Lawrence Erik Kurzius,
  
• Cynthia L Lucchese,